Session Number:

S14

Session Title:

Diabetes therapy and cancer

Session Type:

Symposium

Session Start/End Time:

Thursday, Oct 01, 2009, 4:45 PM - 6:15 PM

Location:

Freud Hall

Presentations:

Chair--E.A.M. Gale;
Diabetes and Metabolism, Southmead Hospital, Bristol, United Kingdom.

Chair--U. Smith;
Dept. of Molecular & Clinical Medicine, Gothenburg University, Sweden.

Introduction--E.A.M. Gale;
Diabetes and Metabolism, Southmead Hospital, Bristol, United Kingdom.

Epidemiology and oral agents (thiazolidinediones and sulfonylureas)--J.A. Johnson;
University of Alberta, Edmonton, AB, Canada.

Insulin and metformin--C.J. Currie;
Department of Medicine, Cardiff University, United Kingdom.

Mechanisms of cancer growth and protection: insulin, IGF-1 and metformin--U. Smith;
Dept. of Molecular & Clinical Medicine, Gothenburg University, Sweden.

Insulin glargine safety overview--J.S. Skyler;
Diabetes Research Institute, University of Miami, United States.

Insulin detemir safety overview--D. Russell-Jones;
Diabetes and Endocrinology, University of Surrey, Guildford, United Kingdom.

Panel discussion

Summary and evaluation--E.A.M. Gale;
Diabetes and Metabolism, Southmead Hospital, Bristol, United Kingdom.